JP2021525746A5 - - Google Patents
Info
- Publication number
- JP2021525746A5 JP2021525746A5 JP2020566737A JP2020566737A JP2021525746A5 JP 2021525746 A5 JP2021525746 A5 JP 2021525746A5 JP 2020566737 A JP2020566737 A JP 2020566737A JP 2020566737 A JP2020566737 A JP 2020566737A JP 2021525746 A5 JP2021525746 A5 JP 2021525746A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- food
- sepiapterin
- administration
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024146283A JP2024178188A (ja) | 2018-05-30 | 2024-08-28 | テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677926P | 2018-05-30 | 2018-05-30 | |
| US62/677,926 | 2018-05-30 | ||
| US201862771397P | 2018-11-26 | 2018-11-26 | |
| US62/771,397 | 2018-11-26 | ||
| US201962822365P | 2019-03-22 | 2019-03-22 | |
| US62/822,365 | 2019-03-22 | ||
| GC201937662 | 2019-05-28 | ||
| GC2019-37662 | 2019-05-28 | ||
| PCT/US2019/034515 WO2019232126A1 (en) | 2018-05-30 | 2019-05-30 | Compositions and methods for increasing tetrahydrobiopterin plasma exposure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024146283A Division JP2024178188A (ja) | 2018-05-30 | 2024-08-28 | テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525746A JP2021525746A (ja) | 2021-09-27 |
| JPWO2019232126A5 JPWO2019232126A5 (https=) | 2022-06-03 |
| JP2021525746A5 true JP2021525746A5 (https=) | 2022-06-03 |
| JP7547215B2 JP7547215B2 (ja) | 2024-09-09 |
Family
ID=68699016
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566737A Active JP7547215B2 (ja) | 2018-05-30 | 2019-05-30 | テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法 |
| JP2024146283A Pending JP2024178188A (ja) | 2018-05-30 | 2024-08-28 | テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024146283A Pending JP2024178188A (ja) | 2018-05-30 | 2024-08-28 | テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12257252B2 (https=) |
| EP (1) | EP3801534B1 (https=) |
| JP (2) | JP7547215B2 (https=) |
| CN (1) | CN112654356A (https=) |
| BR (1) | BR112020024329A2 (https=) |
| CA (1) | CA3102105A1 (https=) |
| DK (1) | DK3801534T3 (https=) |
| FI (1) | FI3801534T3 (https=) |
| MX (1) | MX2020012980A (https=) |
| WO (1) | WO2019232126A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11072614B2 (en) | 2016-11-29 | 2021-07-27 | Ptc Therapeutics Mp, Inc. | Polymorphs of sepiapterin and salts thereof |
| US11130760B2 (en) | 2016-11-29 | 2021-09-28 | Ptc Therapeutics Mp, Inc. | Polymorphic form of sepiapterin |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| EP3801536B1 (en) * | 2018-05-30 | 2024-07-17 | PTC Therapeutics MP, Inc. | Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure |
| CN112654356A (zh) | 2018-05-30 | 2021-04-13 | Ptc医疗Mp公司 | 增加四氢生物蝶呤血浆暴露的组合物和方法 |
| CA3165636A1 (en) * | 2020-01-24 | 2021-07-29 | Neil Smith | Methods for treating parkinson's disease with sepiapterin |
| US12298026B1 (en) | 2021-04-12 | 2025-05-13 | W. L. Gore & Associates, Inc. | Latent energy transfer laminate for plate pack core |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5925323A (ja) | 1982-03-03 | 1984-02-09 | 鐘淵化学工業株式会社 | プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤 |
| US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| CA2228970A1 (en) | 1995-08-18 | 1997-02-27 | Donald W. Landry | Detection of organic compounds through regulation of antibody-catalyzed reactions |
| US6036949A (en) | 1998-03-05 | 2000-03-14 | Amarillo Biosciences, Inc. | Treatment of fibromyalgia with low doses of interferon |
| US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
| FR2859996B1 (fr) | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
| EP1696877A4 (en) | 2003-11-13 | 2010-06-09 | Gen Hospital Corp | PROCESS FOR PAIN TREATMENT |
| US7732599B2 (en) | 2003-11-17 | 2010-06-08 | Biomarin Pharmaceutical Inc. | Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin |
| CA2678125C (en) | 2003-11-17 | 2014-10-14 | Merck Eprova Ag | Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| KR20070005550A (ko) | 2003-11-17 | 2007-01-10 | 바이오마린 파머수티컬 인크. | 대사 장애 치료를 위한 조성물 및 방법 |
| WO2006055511A2 (en) | 2004-11-17 | 2006-05-26 | Biomarin Pharmaceutical Inc. | Stable tablet formulation of tetrahydrobiopterin |
| CA2588994A1 (en) | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| US7582799B2 (en) | 2005-04-28 | 2009-09-01 | Shiratori Pharmaceutical Co., Ltd. | Method for producing hydrazone derivatives |
| US20080075666A1 (en) | 2006-08-25 | 2008-03-27 | Dudley Samuel C Jr | Methods and compositions for treating diastolic dysfunction |
| WO2008128049A2 (en) | 2007-04-11 | 2008-10-23 | Biomarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| US20110144117A1 (en) | 2008-08-12 | 2011-06-16 | Orpha Swiss Gmbh | Pharmaceutical Dosage Form Containing Tetrahydrobiopterin |
| EP2562176B1 (en) | 2010-04-22 | 2018-08-15 | Nihon University | Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| CA2828685C (en) | 2011-03-01 | 2018-05-29 | Rubicon Research Private Limited | Stable compositions of tetrahydrobiopterin |
| US9216178B2 (en) * | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
| IN2014DN09053A (https=) | 2012-05-07 | 2015-05-22 | Shiratori Pharm | |
| US10365267B2 (en) | 2014-10-31 | 2019-07-30 | Children's Medical Center Corporation | Methods and assays relating to sepiapterin reductase inhibition |
| US11130760B2 (en) | 2016-11-29 | 2021-09-28 | Ptc Therapeutics Mp, Inc. | Polymorphic form of sepiapterin |
| US11072614B2 (en) * | 2016-11-29 | 2021-07-27 | Ptc Therapeutics Mp, Inc. | Polymorphs of sepiapterin and salts thereof |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| CN112654356A (zh) | 2018-05-30 | 2021-04-13 | Ptc医疗Mp公司 | 增加四氢生物蝶呤血浆暴露的组合物和方法 |
| AU2019277372B2 (en) * | 2018-05-30 | 2024-12-19 | Ptc Therapeutics Mp, Inc. | Pharmaceutically acceptable salts of sepiapterin |
| EP3801536B1 (en) | 2018-05-30 | 2024-07-17 | PTC Therapeutics MP, Inc. | Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure |
| IL290321B1 (en) | 2019-08-05 | 2026-04-01 | Ptc Therapeutics Inc | Use of spiapterin and its metabolites for radiation exposure treatment |
| IL291565B1 (en) | 2019-09-25 | 2026-04-01 | Ptc Therapeutics Inc | Method for treating phenylalanine irregularity |
-
2019
- 2019-05-30 CN CN201980050730.3A patent/CN112654356A/zh active Pending
- 2019-05-30 MX MX2020012980A patent/MX2020012980A/es unknown
- 2019-05-30 WO PCT/US2019/034515 patent/WO2019232126A1/en not_active Ceased
- 2019-05-30 EP EP19810058.8A patent/EP3801534B1/en active Active
- 2019-05-30 JP JP2020566737A patent/JP7547215B2/ja active Active
- 2019-05-30 US US17/059,632 patent/US12257252B2/en active Active
- 2019-05-30 CA CA3102105A patent/CA3102105A1/en active Pending
- 2019-05-30 BR BR112020024329-9A patent/BR112020024329A2/pt unknown
- 2019-05-30 FI FIEP19810058.8T patent/FI3801534T3/fi active
- 2019-05-30 DK DK19810058.8T patent/DK3801534T3/da active
-
2024
- 2024-08-28 JP JP2024146283A patent/JP2024178188A/ja active Pending
-
2025
- 2025-03-04 US US19/070,026 patent/US20250195529A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525746A5 (https=) | ||
| JP2021525729A5 (https=) | ||
| EP2698147B1 (en) | Oral Film Formulations Comprising Dapoxetine and Tadalafil | |
| JP2024069192A5 (https=) | ||
| EP3236943A1 (en) | Compositions for ileo-jejunal drug delivery | |
| AU2009273361B2 (en) | Pharmaceutical formulation for treating the upper digestive tract | |
| WO2013081565A1 (en) | Pharmaceutical compositions comprising roflumilast and terbutaline | |
| WO2022104091A1 (en) | Rapidly infusing compositions for oral mucosal delivery and methods | |
| WO2020148271A1 (en) | Modified release tablet formulations containing phosphodiesterase inhibitors | |
| JP5235416B2 (ja) | 固体投与形中のテトラサイクリン金属錯体 | |
| EP2374479A2 (en) | Controlled-release composition for producing sustained-release preparation containing udenafil | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| JPWO2019232126A5 (https=) | ||
| EP3236949B1 (en) | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof | |
| JP2025506890A (ja) | 治療用の化合物、製剤、およびそれらの使用 | |
| JPWO2019232130A5 (https=) | ||
| JP2021509409A5 (https=) | ||
| JP2007530692A (ja) | ６−メルカプトプリンの改良された製剤 | |
| CN106456998B (zh) | 西格列汀丹宁酸盐复合物 | |
| EP2709596A1 (en) | Effervescent formulations comprising dexketoprofen | |
| JP7738832B2 (ja) | 低亜鉛血症治療剤 | |
| WO2025023901A1 (en) | The pharmaceutical combination comprising phosphodiesterase type-5 inhibitor and l-arginine | |
| AU2023289786A1 (en) | An orodispersible pharmaceutical composition of baclofen and its process of preparation | |
| CN116847842A (zh) | Irak4降解剂和其用途 | |
| JP5977672B2 (ja) | イブプロフェンリシナートの経口投与用の懸濁液 |